Cube Labs SpA (MIL:CUBE) Total Receivables : €4.52 Mil (As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Cube Labs SpA Total Receivables?

Cube Labs SpA's Total Receivables for the quarter that ended in Jun. 2023 was €4.52 Mil.

Cube Labs SpA Total Receivables Historical Data

The historical data trend for Cube Labs SpA's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cube Labs SpA Total Receivables Chart

Cube Labs SpA Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Total Receivables

1.56

0.67

1.52

2.44

3.54

Cube Labs SpA Semi-Annual Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Total Receivables	Get a 7-Day Free Trial			-	2.44	2.83	3.54	4.52

Cube Labs SpA Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Cube Labs SpA Total Receivables Related Terms

Thank you for viewing the detailed overview of Cube Labs SpA's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Cube Labs SpA (MIL:CUBE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Cube Labs SpA (MIL:CUBE) » Definitions » Total Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Giulio Caccini, 1, Rome, ITA, 00186

Website

https://cube-labs.com

Cube Labs SpA operates as a venture builder that enables innovation in the healthcare technology space. The company is engaged in attracting sources of financing and providing entrepreneurial and operational support to the companies to develop healthcare technologies for the market.